Is CryoCell International Inc (CCEL) overvalued? · P/E 490, $39.6M cap
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
This page asks whether CryoCell International Inc (CCEL) looks expensive on cached numbers — not a short thesis.
No cached income statement for CCEL, so there is no earnings base to call rich or cheap.
CCEL currently screens at market cap $39.6M and trailing P/E 490.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CCEL 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CCEL stock page for the full model, not this heading.
Not investment advice.